Jan Lemmens

Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer

Luc Dirix, Roberto Salgado, Reinhilde Weytjens et al. · British Journal of Cancer · 2002 · 204 citations · Full text

Medicine, Cancer Biology, Oncology +17

BM 13.177, A SELECTIVE BLOCKER OF PLATELET AND VESSEL WALL THROMBOXANE RECEPTORS, IS ACTIVE IN MAN

Paolo Gresele, Jef Arnout, W. J. Janssens et al. · The Lancet · 1984 · 76 citations

Medicine, Hematology, Pharmacology +14

Adequate iron chelation therapy for at least six months improves survival in transfusion-dependent patients with lower risk myelodysplastic syndromes

Michel Delforge, Dominik Selleslag, Yves Béguin et al. · Leukemia Research · 2014 · 66 citations

Medicine, Hematology, Pharmacology +16

Monocytes are activated in patients with myelodysplastic syndromes and can contribute to bone marrow failure through CD40–CD40L interactions with T helper cells

Stef Meers, Ahmad Kasran, Louis Boon et al. · Leukemia · 2007 · 20 citations · Full text

Life Sciences, Hematology, Immunology +15

Contempo: Preliminary Results in First-Line Treatment of Follicular Lymphoma with the Oral Dual PI3K-δ,γ Inhibitor, Duvelisib, in Combination with Rituximab or Obinutuzumab

Carla Casulo, Juan‐Manuel Sancho, Koen Van Eygen et al. · Blood · 2016 · 15 citations

Pharmacy, Pharmacology, Pharmacotherapy +7